Brain Scientific, Inc. (BRSF) financial statements (2020 and earlier)

Company profile

Business Address 205 EAST 42ND STREET, 14TH FLOOR
NEW YORK, NY 10017
State of Incorp. NV
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments26116400
Cash and cash equivalents26116400
Receivables6   
Inventory, net of allowances, customer advances and progress billings  23
Inventory  23
Prepaid expense1   
Other undisclosed current assets2215  
Total current assets:28917824
Noncurrent Assets
Property, plant and equipment22  
Total noncurrent assets:22  
TOTAL ASSETS:29118024
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:299140196
Accounts payable  196
Other undisclosed accounts payable and accrued liabilities299140  
Debt499 7035
Due to related parties323508643
Other liabilities65  
Other undisclosed current liabilities5932  
Total current liabilities:1,18722717584
Noncurrent Liabilities
Liabilities, other than long-term debt 7  
Other liabilities 7  
Total noncurrent liabilities: 7  
Total liabilities:1,18723417584
Stockholders' equity
Stockholders' equity attributable to parent(896)(54)(173)(81)
Common stock19191010
Additional paid in capital2,7572,59500
Accumulated other comprehensive income0   
Accumulated deficit(3,672)(2,668)(183)(91)
Total stockholders' equity:(896)(54)(173)(81)
TOTAL LIABILITIES AND EQUITY:29118024

Income statement (P&L) ($ in thousands)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
Revenues489587 
Other income218  
Cost of revenue
(Cost of Goods and Services Sold)
(387)(34)(1) 
Gross profit:102246 
Operating expenses(1,072)(1,309)(92)(90)
Operating loss:(970)(1,285)(86)(90)
Nonoperating expense(31)(141)(6)(0)
Debt instrument, convertible, beneficial conversion feature 123  
Interest and debt expense(33)(159)(6)(0)
Other undisclosed income from continuing operations before equity method investments, income taxes3315960
Loss from continuing operations before income taxes:(1,002)(1,426)(92)(91)
Income tax expense(2)   
Net loss available to common stockholders, diluted:(1,004)(1,426)(92)(91)

Comprehensive Income ($ in thousands)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
Net loss:(1,004)(1,426)(92)(91)
Comprehensive loss:(1,004)(1,426)(92)(91)
Other undisclosed comprehensive income, net of tax, attributable to parent0   
Comprehensive loss, net of tax, attributable to parent:(1,003)(1,426)(92)(91)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: